Troglitazone Reduction of Intracellular Mycobacterium tuberculosis Survival Via Macrophage Autophagy Through LKB1-AMPKα Signaling
The Journal of Infectious Diseases · 2025
DOI: 10.1093/infdis/jiae523 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Jing Bi und 13 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Infectious Diseases, Guangdong Provincial Clinical Research Center for Tuberculosis, Shenzhen Third People's Ho…. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Autophagy, Protein Serine-Threonine Kinases, AMP-Activated Protein Kinases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Plan, Guangdong Science Fund for Distinguished Young Scholars.
Abstract (Originalsprache)
Tuberculosis caused by Mycobacterium tuberculosis (Mtb), results in significant disease and death worldwide. Host-directed therapy, including conventional drugs, is a promising antituberculosis strategy that shows synergistic antibacterial effects when combined with antituberculosis drugs. Here, the mycobactericidal effect of 3 antidiabetic drugs was examined. Of these, only troglitazone (Trog) enhanced the antimycobacterial effect in vitro and in vivo. This was due to Trog-mediated autophagy activation. Moreover, a knock-down experiment revealed that Trog activated autophagy and exhibited antimycobacterial activity through the serine/threonine-protein kinase STK11 (LKB1)-5'-AMP-activated protein kinase (AMPK) signaling pathway. Molecular docking and coimmunoprecipitation experiments demonstrated that Trog promoted LKB1 phosphorylation and activation by targeting STE20-related kinase adapter protein alpha (STRADA). Finally, we found that Trog inhibited the intracellular survival of clinical isoniazid-resistant Mtb, and the combination of Trog and isoniazid showed additive antibacterial effects against Mtb H37Rv. Taken together, antidiabetic Trog may be repurposed as a candidate for host-directed therapy and combined with first-line antituberculosis drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Clinical Research Center for Infectious Diseases, Guangdong Provincial Clinical Research Center for Tuberculosis, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, China.
- Shenzhen Bay Laboratory, Pingshan Translational Medicine Center, Shenzhen, China.
- Department of Tuberculosis, Guangxi Chest Hospital, Liuzhou, China.
ORCID-Profile: Guoliang Zhang
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Plan
- Guangdong Science Fund for Distinguished Young Scholars
- State Key Laboratory of Respiratory Diseases Open Project
- Shenzhen Scientific and Technological Foundation
- Sanming Project of Medicine in Shenzhen
- Guangxi Scientific and Technological Foundation
Zitieren
APA
Bi, J., Guo, Q., Gong, Y., Chen, X., Wu, H., Song, L., Xu, Y., Ou, M., Wang, Z., Chen, J., Jiang, C., Liu, A., Li, G., & Zhang, G. (2025). Troglitazone Reduction of Intracellular Mycobacterium tuberculosis Survival Via Macrophage Autophagy Through LKB1-AMPKα Signaling. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae523
Vancouver
Bi J, Guo Q, Gong Y, Chen X, Wu H, Song L, et al. Troglitazone Reduction of Intracellular Mycobacterium tuberculosis Survival Via Macrophage Autophagy Through LKB1-AMPKα Signaling. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiae523
BibTeX
@article{Bi2025,
author = {Bi, Jing and Guo, Qinglong and Gong, Yaqi and Chen, Xi and Wu, Haojia and Song, Li and Xu, Yating and Ou, Min and Wang, Zhaoqin and Chen, Jiean and Jiang, Chenran and Liu, Aimei and Li, Guobao and Zhang, Guoliang},
title = {Troglitazone Reduction of Intracellular Mycobacterium tuberculosis Survival Via Macrophage Autophagy Through LKB1-AMPKα Signaling},
journal = {The Journal of Infectious Diseases},
year = {2025},
doi = {10.1093/infdis/jiae523}
}
EUVIMED